XML 51 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Valuation Method Used to Calculate Level 3 Liabilities Measured at Estimated Fair Value of Contingent Consideration Related to Acquisition (Detail)
$ in Thousands
3 Months Ended
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Contingent consideration $ 10,331 $ 10,490
ECP Entwicklungsgesellschaft mbH | Discount Rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Alternative investment, measurement input 21  
Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Contingent consideration $ 10,331 $ 10,490
Level 3 | ECP Entwicklungsgesellschaft mbH    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Milestone Payment 15,000  
Contingent consideration 10,331  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Milestone Payment 7,000  
Contingent consideration $ 5,712  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Base Case Scenario | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Probability of occurrence 40.00%  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Minimum | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Projected fiscal year of milestone payments 2019  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Minimum | Various Upside and Downside Scenarios | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Probability of occurrence 10.00%  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Maximum | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Projected fiscal year of milestone payments 2022  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Maximum | Various Upside and Downside Scenarios | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Probability of occurrence 40.00%  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Discount Rate | Minimum | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Alternative investment, measurement input 3.9  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Discount Rate | Maximum | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Alternative investment, measurement input 4.2  
Level 3 | ECP Entwicklungsgesellschaft mbH | Monte Carlo simulation model | Revenue-based milestone    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Milestone Payment $ 8,000  
Contingent consideration $ 4,619  
Level 3 | ECP Entwicklungsgesellschaft mbH | Monte Carlo simulation model | Revenue-based milestone | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Probability of payment 78.00%  
Level 3 | ECP Entwicklungsgesellschaft mbH | Monte Carlo simulation model | Revenue-based milestone | Minimum | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Projected fiscal year of milestone payments 2024  
Level 3 | ECP Entwicklungsgesellschaft mbH | Monte Carlo simulation model | Revenue-based milestone | Maximum | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Projected fiscal year of milestone payments 2035  
Level 3 | ECP Entwicklungsgesellschaft mbH | Monte Carlo simulation model | Revenue-based milestone | Discount Rate | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Alternative investment, measurement input 14  
Level 3 | ECP Entwicklungsgesellschaft mbH | Monte Carlo simulation model | Revenue-based milestone | Expected Volatility for Forecasted Revenues | Contingent Consideration    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Alternative investment, measurement input 50